Yuen, C., Riedell, P., Artz, A., Kosuri, S., Kelly, T., Wu, S., . . . Bishop, M. (2020). NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY. Neuro Oncol.
Citação norma ChicagoYuen, Carlen, et al. "NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY." Neuro Oncol 2020.
MLA引文Yuen, Carlen, et al. "NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY." Neuro Oncol 2020.
警告：這些引文格式不一定是100％准確.